Prediction of HBsAg loss after cessation of entecavir therapy
- PMID: 39299458
- DOI: 10.1016/j.jhep.2024.09.011
Prediction of HBsAg loss after cessation of entecavir therapy
Conflict of interest statement
Conflict of interest The authors have no potential competing interests that could inappropriately influence (bias) their work. Please refer to the accompanying ICMJE disclosure forms for further details.
Publication types
LinkOut - more resources
Full Text Sources
